These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 13736381)

  • 1. Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville, Congo. 3. Safety and efficacy during the first 21 months of study.
    PLOTKIN SA; LEBRUN A; COURTOIS G; KOPROWSKI H
    Bull World Health Organ; 1961; 24(6):785-92. PubMed ID: 13736381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville. Belgian Congo. 2. Studies of the safety and efficacy of vaccination.
    PLOTKIN SA; LEBRUN A; KOPROWSKI H
    Bull World Health Organ; 1960; 22(3-4):215-34. PubMed ID: 14433516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with the CHAT strain of type 1 attenuated poliomyelities virus in Leopoldville, Belgian Congo. 1. Description of the city, its history of poliomyelitis, and the plan of the vaccination campaign.
    LEBRUN A; CERF J; GELFAND HM; COURTOIS G; PLOTKIN SA; KOPROWSKI H
    Bull World Health Organ; 1960; 22(3-4):203-13. PubMed ID: 14415050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic markers and serological identity of wild and attenuated strains of type-1 poliovirus, with special emphasis on strains isolated from patients during an epidemic in the Belgian Congo.
    KOPROWSKI H; NORTON TW; WECKER E; GARD S
    Bull World Health Organ; 1960; 22(3-4):243-53. PubMed ID: 14410972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against poliomyelitis in Poland with types 1 and 3 attenuated viruses of Koprowski. 1. Virological studies of the vaccine strains and serological studies of the vaccinated population.
    PRZESMYCKI F; DOBROWOLSKA H; MIRSKI B; WIOR H; STANCZYK R; ZALESKA H
    Bull World Health Organ; 1962; 26(6):733-43. PubMed ID: 14489069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
    Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating vaccine-derived poliovirus type 2 outbreak in Democratic Republic of Congo 2011-2012].
    Bazira L; Coulibaly T; Mayenga M; Ncharre C; Yogolelo R; Mbule A; Moudzeo H; Lwamba P; Mulumba AW; Cabore J
    Bull Soc Pathol Exot; 2015 Oct; 108(4):235-41. PubMed ID: 26288132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with attenuated type I poliovirus, the Chat strain. 3. Antibody response and spread of virus in schoolchildren.
    Böttiger M; Böttiger E; Zetterberg B
    Acta Paediatr Scand; 1966 Jul; 55(4):422-31. PubMed ID: 5966343
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccination with attenuated type I poliovirus, the Chat strain. II. Transmission of virus in relation to age.
    Böttiger M; Gard S; Zetterberg B
    Acta Paediatr Scand; 1966 Jul; 55(4):416-21. PubMed ID: 5966342
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary report on mass vaccination of man with live attenuated poliomyelitis virus in the Belgian Congo and Ruanda-Urundi.
    COURTOIS G; FLACK A; JERVIS GA; KOPROWSKI H; NINANE G
    Br Med J; 1958 Jul; 2(5090):187-90. PubMed ID: 13560820
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological strain specificity within type 1 poliovirus.
    GARD S
    Bull World Health Organ; 1960; 22(3-4):235-42. PubMed ID: 13826481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with attenuated type I poliovirus, the Chat strain. I. A study of 20 families.
    Böttiger M; Gard S; Lagercrantz R
    Acta Paediatr Scand; 1966 Jul; 55(4):405-15. PubMed ID: 5966341
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent results of mass immunization against poliomyelitis with Koprowski strains of attenuated live poliovirus.
    PLOTKIN SA
    Am J Public Health Nations Health; 1962 Jun; 52(6):946-60. PubMed ID: 14487227
    [No Abstract]   [Full Text] [Related]  

  • 14. Poliomyelitis survey in Middle-East countries.
    Brigaud M; Aymard M; Thouvenot D; Chomel JJ; Mahmood RA; Mathew PP; Jafar AK
    Dev Biol Stand; 1978; 41():149-58. PubMed ID: 223907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary report on vaccination in Croatia against poliomyelitis with type 1 (CHAT) and type 3 (W-Fox) attenuated polioviruses of Koprowski.
    Ikić D; Jancikić B; Lulić V; Cuk D; Juzbasić M; Manhalter T; Sindik A
    Bull World Health Organ; 1963; 28(2):217-23. PubMed ID: 20604139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years.
    Böttiger M; Zetterberg B; Salenstedt CR
    Bull World Health Organ; 1972; 46(2):141-9. PubMed ID: 4537478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [History of development of the live poliomyelitis vaccine from Sabin attenuated strains in 1959 and idea of poliomyelitis eradication].
    Lashkevich VA
    Vopr Virusol; 2013; 58(1):4-10. PubMed ID: 23785754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against poliomyelitis in Poland with types 1 and 3 attenuated viruses of Koprowski: 2. Epidemiological evaluation of results of mass vaccination, 1959-60.
    Kostrzewski J; Kulesza A; Załeska H
    Bull World Health Organ; 1962; 26(6):745-58. PubMed ID: 20604115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poliomyelitis vaccine; epidemiologic observations on the safety and effectiveness in California in 1955.
    MAGOFFIN RL
    Calif Med; 1956 Aug; 85(2):79-86. PubMed ID: 13343011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.